Cargando…

Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson’s disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that α-syn deposition is also present within the gut and other periph...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes, Juan F., Ekmark-Léwen, Sara, Perdiki, Marina, Klingstedt, Therése, Hoffmann, Alana, Wiechec, Emilia, Nilsson, Per, Nilsson, K. Peter R., Alafuzoff, Irina, Ingelsson, Martin, Hallbeck, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980682/
https://www.ncbi.nlm.nih.gov/pubmed/33743820
http://dx.doi.org/10.1186/s40478-021-01136-3
_version_ 1783667476847919104
author Reyes, Juan F.
Ekmark-Léwen, Sara
Perdiki, Marina
Klingstedt, Therése
Hoffmann, Alana
Wiechec, Emilia
Nilsson, Per
Nilsson, K. Peter R.
Alafuzoff, Irina
Ingelsson, Martin
Hallbeck, Martin
author_facet Reyes, Juan F.
Ekmark-Léwen, Sara
Perdiki, Marina
Klingstedt, Therése
Hoffmann, Alana
Wiechec, Emilia
Nilsson, Per
Nilsson, K. Peter R.
Alafuzoff, Irina
Ingelsson, Martin
Hallbeck, Martin
author_sort Reyes, Juan F.
collection PubMed
description Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson’s disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that α-syn deposition is also present within the gut and other peripheral organs outside the central nervous system (CNS). In the current study, we demonstrate for the first time that α-syn pathology also accumulates within the liver, the main organ responsible for substance clearance and detoxification. We further demonstrate that cultured human hepatocytes readily internalize oligomeric α-syn assemblies mediated, at least in part, by the gap junction protein connexin-32 (Cx32). Moreover, we identified a time-dependent accumulation of α-syn within the liver of three different transgenic (tg) mouse models expressing human α-syn under CNS-specific promoters, despite the lack of α-syn mRNA expression within the liver. Such a brain-to-liver transmission route could be further corroborated by detection of α-syn pathology within the liver of wild type mice one month after a single striatal α-syn injection. In contrast to the synucleinopathy models, aged mice modeling AD rarely show any amyloid-beta (Aß) deposition within the liver. In human post-mortem liver tissue, we identified cases with neuropathologically confirmed α-syn pathology containing α-syn within hepatocellular structures to a higher degree (75%) than control subjects without α-syn accumulation in the brain (57%). Our results reveal that α-syn accumulates within the liver and may be derived from the brain or other peripheral sources. Collectively, our findings indicate that the liver may play a role in the clearance and detoxification of pathological proteins in PD and related synucleinopathies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01136-3.
format Online
Article
Text
id pubmed-7980682
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79806822021-03-22 Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease Reyes, Juan F. Ekmark-Léwen, Sara Perdiki, Marina Klingstedt, Therése Hoffmann, Alana Wiechec, Emilia Nilsson, Per Nilsson, K. Peter R. Alafuzoff, Irina Ingelsson, Martin Hallbeck, Martin Acta Neuropathol Commun Research Alpha-synuclein (α-syn) aggregation is the hallmark pathological lesion in brains of patients with Parkinson’s disease (PD) and related neurological disorders characterized as synucleinopathies. Accumulating evidence now indicates that α-syn deposition is also present within the gut and other peripheral organs outside the central nervous system (CNS). In the current study, we demonstrate for the first time that α-syn pathology also accumulates within the liver, the main organ responsible for substance clearance and detoxification. We further demonstrate that cultured human hepatocytes readily internalize oligomeric α-syn assemblies mediated, at least in part, by the gap junction protein connexin-32 (Cx32). Moreover, we identified a time-dependent accumulation of α-syn within the liver of three different transgenic (tg) mouse models expressing human α-syn under CNS-specific promoters, despite the lack of α-syn mRNA expression within the liver. Such a brain-to-liver transmission route could be further corroborated by detection of α-syn pathology within the liver of wild type mice one month after a single striatal α-syn injection. In contrast to the synucleinopathy models, aged mice modeling AD rarely show any amyloid-beta (Aß) deposition within the liver. In human post-mortem liver tissue, we identified cases with neuropathologically confirmed α-syn pathology containing α-syn within hepatocellular structures to a higher degree (75%) than control subjects without α-syn accumulation in the brain (57%). Our results reveal that α-syn accumulates within the liver and may be derived from the brain or other peripheral sources. Collectively, our findings indicate that the liver may play a role in the clearance and detoxification of pathological proteins in PD and related synucleinopathies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-021-01136-3. BioMed Central 2021-03-20 /pmc/articles/PMC7980682/ /pubmed/33743820 http://dx.doi.org/10.1186/s40478-021-01136-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Reyes, Juan F.
Ekmark-Léwen, Sara
Perdiki, Marina
Klingstedt, Therése
Hoffmann, Alana
Wiechec, Emilia
Nilsson, Per
Nilsson, K. Peter R.
Alafuzoff, Irina
Ingelsson, Martin
Hallbeck, Martin
Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
title Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
title_full Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
title_fullStr Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
title_full_unstemmed Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
title_short Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
title_sort accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with parkinson’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980682/
https://www.ncbi.nlm.nih.gov/pubmed/33743820
http://dx.doi.org/10.1186/s40478-021-01136-3
work_keys_str_mv AT reyesjuanf accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT ekmarklewensara accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT perdikimarina accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT klingstedttherese accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT hoffmannalana accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT wiechecemilia accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT nilssonper accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT nilssonkpeterr accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT alafuzoffirina accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT ingelssonmartin accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease
AT hallbeckmartin accumulationofalphasynucleinwithintheliverpotentialroleintheclearanceofbrainpathologyassociatedwithparkinsonsdisease